RankAlpha logo
Back to Rankings

ZLAB

Zai LabF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ZLAB vs peer average
34/100
ZLAB vs. peer average (F vs. D)
Grade spread
C 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

NKTR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.98B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerNKTRNektar Therapeutics
ZLAB
Zai Lab
NKTR
Nektar Therapeutics
Grade
F
D
Momentum
12
17
Value
41
41
Sentiment
-
77
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs NKTR

ZLAB / NKTR
Grade Position
Below peers
ZLAB vs. peer average (F vs. D)
34/100
Momentum
12
NKTR
Value
41
ZLAB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ZLAB
1
NKTR
Nektar Therapeutics Common
D
40/100
-1
2
AUPH
Aurinia Pharmaceuticals Inc Common
C
60/100
-2
3
PHVS
Pharvaris NV Common
C
60/100
-2
4
TRVI
Trevi Therapeutics Inc Common
D
40/100
-1
5
RXRX
Recursion Pharmaceuticals Inc Class A Common
F
20/100
Even
NKTR is the first peer returned for this comparison set.